Selegiline Hydrochloride Capsule
Product Images NDC 70954-504

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Selegiline Hydrochloride (NDC 70954-504). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novitium Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

FDA Label Image

Table (Table)

This text reports the incidence of treatment-emergent adverse experiences in a clinical trial comparing selegiline hydrochloride to a placebo. Nausea was the most frequently reported event with three patients in the selegiline hydrochloride group reporting it. Other events reported were dizziness/lightheadedness/fainting, abdominal pain, confusion, hallucinations, dry mouth, vivid dreams, dyskinesias, headache, ache, anxiety/tension, diarrhea, insomnia, lethargy, leg pain, low back pain, malaise, palpitations, urinary retention, and weight loss, however, the occurrence of these events varied between one or none in either or both groups.*

FDA Label Image

Label-1000ct (Label 1000ct)

This is a medication with National Drug Code (NDC) 70954-504-20, containing 1000 capsules, each capsule consisting of Selegiline Hydrochloride, USP in a dosage of 5mg. The usual adult dosage is two capsules daily. It should be stored in a tightly sealed, light-resistant container, at a temperature between 20° and 25°C (68° to 77°F). It is recommended to keep this drug out of the reach of children. This medication is manufactured by Novitium Pharma LLC, located at 70 Lake Drive, East Windsor, New Jersey 08520. The drug was issued in January 2021.*

FDA Label Image

Label-60ct (Label 60ct)

This text describes a medication with the NDC code 70954-504-10, which comes in a bottle of 60 capsules. The medication is Selegiline Hydrochloride, each capsule containing 5mg of the drug. The recommended adult dosage is two capsules per day, and the medication should be stored in a light-resistant container at 20° to 25°C. The medication should be kept out of the reach of children. This medication was manufactured by Novitium Pharma LLC and the description appears to be their labeling information issued in January 2021.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.